Human papillomaviruses (HPVs) are highly prevalent and potent human pathogens that cause over 5% of all human cancers, including cervical cancer (CxCa) and a subset of head and neck cancers (HNC). HPV-associated cancers result in a half of a million deaths every year worldwide. Our research group focuses on investigating virus-host interactions, particularly in the context of host immunity, to develop effective preventive and therapeutic strategies for HPV-associated cancers.